Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-03

Clinical Trial Update: Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing VIAject insulin with regular human insulin and insulin lispro in patients with Type 2 diabetes mellitus completed, assessing mealtime va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regular human insulin (human insulin (regular))
  • VIAject (insulin VIAject)
  • insulin lispro (insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED